- SkinMedica®, by the makers of
BOTOX® Cosmetic (onabotulinumtoxinA) launches the
first and only product to use a proprietary complex of five forms
of Hyaluronic Acid (HA) and Hydra Collagen, plus Advanced
VITISENSCE® Technology for deeper hydration
IRVINE,
Calif., Aug. 27, 2024 /PRNewswire/ -- For 25
years, SkinMedica® has been at the forefront of
science-based skincare solutions, and today, Allergan Aesthetics,
an AbbVie company (NYSE: ABBV), announced the launch of its next
generation hydration product: SkinMedica®
HA5® Hydra Collagen Replenish + Restore Hydrator. The
product is specifically designed to deliver unparalleled hydration,
visible plumpness, and radiance to facial skin.
"We revolutionized the way people approached skin hydration in
2016 with the launch of our first HA5® Rejuvenating
Hydrator, which continues to win industry awards and be a consumer
favorite," said Jasson Gilmore,
Senior Vice President of U.S. Aesthetics at Allergan Aesthetics.
"Now we've taken the best of the original product and improved
on it to enhance skin health and provide even deeper
hydration."
The new SkinMedica® HA5® Hydra Collagen
Replenish + Restore Hydrator has double the amount of hyaluronic
acid than the original and now contains Hydra Collagen and Advanced
VITISENSCE® Technology, which support the skin's natural
ability to attract and retain moisture while providing instant
hydration and smoothness. The product is appropriate for all skin
types, helps fortify the skin barrier, and provides hydration for
up to 48 hours1.
For optimal results, HA5® Hydra Collagen Replenish +
Restore Hydrator can be complemented with an in-office
DiamondGlow® facial using SkinMedica®
HA5® Hydra Collagen Pro-Infusion Serum. Clinical studies
show that participants using both the at-home and in-office
treatment reported their skin appeared three-times more radiant,
more hydrated, and visibly plumper after just one
use1.
"Regardless of age, gender, or ethnicity, people experience
dehydrated skin at some point. Skin hydration is critical for skin
that not only looks smooth and radiant, but also feels healthy and
firm," said Dr. Shannon Humphrey,
board-certified dermatologist. "Daily application of the
HA5® Hydra Collagen Hydrator, supplemented with
DiamondGlow® treatments every 4-6 weeks is an effective
combination that delivers radiant, glowing, and hydrated skin."
SkinMedica® HA5® Hydra Collagen Replenish
+ Restore Hydrator MSRP $192 is
available for purchase at SkinMedica.com. To experience the
SkinMedica® HA5® Hydra Collagen
Pro-Infusion Serum for DiamondGlow®, find a provider by
visiting DiamondGlow.com. For more information follow @SkinMedica
on Instagram.
To learn more and earn points on your favorite aesthetic
treatments, including SkinMedica®, join Allē, the number
one aesthetics loyalty program at Alle.com.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skincare,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information, visit
www.allerganaesthetics.com
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines and solutions that solve serious
health issues today and address the medical challenges of tomorrow.
We strive to have a remarkable impact on people's lives across
several key therapeutic areas – immunology, oncology, neuroscience,
and eye care – and products and services in our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X
(formerly Twitter), and YouTube.
Forward-Looking Statements
Some statements in this
news release are, or may be considered, forward-looking statements
for purposes of the Private Securities Litigation Reform Act of
1995. The words "believe," "expect," "anticipate," "project" and
similar expressions and uses of future or conditional verbs,
generally identify forward-looking statements. AbbVie cautions that
these forward-looking statements are subject to risks and
uncertainties that may cause actual results to differ materially
from those expressed or implied in the forward-looking statements.
Such risks and uncertainties include, but are not limited to,
challenges to intellectual property, competition from other
products, difficulties inherent in the research and development
process, adverse litigation or government action, and changes to
laws and regulations applicable to our industry. Additional
information about the economic, competitive, governmental,
technological and other factors that may affect AbbVie's operations
is set forth in Item 1A, "Risk Factors," of AbbVie's 2023 Annual
Report on Form 10-K, which has been filed with the Securities and
Exchange Commission, as updated by its subsequent Quarterly Reports
on Form 10-Q. AbbVie undertakes no obligation, and specifically
declines, to release publicly any revisions to forward-looking
statements as a result of subsequent events or developments, except
as required by law.
BOTOX® COSMETIC IMPORTANT SAFETY INFORMATION AND
APPROVED USES
Approved Uses
BOTOX® Cosmetic is a prescription
medicine that is injected into muscles and used to temporarily
improve the look of moderate to severe forehead lines, crow's feet
lines, and frown lines between the eyebrows in
adults.
IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that
can be life threatening. Get medical help right away if you have
any of these problems any time (hours to weeks) after injection of
BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to
weakening of associated muscles, can be severe and result in loss
of life. You are at the highest risk if these problems are
pre-existing before injection. Swallowing problems may last for
several months.
- Spread of toxin effects. The effect of botulinum toxin
may affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble
swallowing.
BOTOX® Cosmetic dosing units are not the same as,
or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin
effect when BOTOX® Cosmetic has been used at the
recommended dose to treat frown lines, crow's feet lines, and/or
forehead lines.
BOTOX® Cosmetic may cause loss of strength or general
muscle weakness, vision problems, or dizziness within hours to
weeks of taking BOTOX® Cosmetic. If this happens, do
not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been
reported. They include: itching, rash, red itchy welts,
wheezing, asthma symptoms, or dizziness or feeling faint. Get
medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if
you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for ingredients);
had an allergic reaction to any other botulinum toxin product such
as Myobloc® (rimabotulinumtoxinB), Dysport®
(abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA);
have a skin infection at the planned injection site.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou
Gehrig's disease, myasthenia gravis, or Lambert-Eaton
syndrome, as you may be at increased risk of serious side effects
including difficulty swallowing and difficulty breathing from
typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical
conditions, including: plans to have surgery; had surgery
on your face; have trouble raising your eyebrows; drooping eyelids;
any other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can harm
your unborn baby); are breast-feeding or plan to (it is not known
if BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you
take, including prescription and over-the-counter
medicines, vitamins, and herbal supplements. Using
BOTOX® Cosmetic with certain other medicines may cause
serious side effects. Do not start any new medicines until you have
told your doctor that you have received BOTOX® Cosmetic
in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or
Xeomin® in the past (tell your doctor exactly which
product you received); have recently received an antibiotic by
injection; take muscle relaxants; take an allergy or cold medicine;
take a sleep medicine; take aspirin-like products or blood
thinners.
Other side effects of BOTOX® Cosmetic include:
dry mouth; discomfort or pain at the injection site; tiredness;
headache; neck pain; and eye problems: double vision, blurred
vision, decreased eyesight, drooping eyelids and eyebrows, swelling
of your eyelids and dry eyes.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full Product
Information including Boxed Warning and Medication
Guide.
DiamondGlow® Important
Information
Uses
The DiamondGlow®
device is a general dermabrasion device that gently removes the top
layer of skin and delivers topical cosmetic serums onto the
skin.
Important Safety Information
The
DiamondGlow® treatment is not for everyone. You should
not have a DiamondGlow® treatment if you have
compromised skin quality. Tell your provider if you are pregnant or
lactating, or if you have any medical conditions, including
allergies, and if you are using topical medications on the area to
be treated.
Typical side effects include a scratchy, stinging sensation
during the treatment and temporary tightness, redness or slight
swelling after the treatment. Rare serious side effects may also
occur and include severe skin irritation and allergic
reactions.
SkinMedica® Pro-Infusion Serums
Disclaimer
SkinMedica® Pro-Infusion Serums are
intended to meet the FDA's definition of a cosmetic product, an
article applied to the human body to cleanse, beautify, promote
attractiveness, and alter appearances. These products are not
intended to be drugs that diagnose, treat, cure, or prevent any
disease or condition. These products have not been approved by the
FDA and the statements have not been evaluated by the FDA.
Please talk to your provider for additional information.
SkinMedica® Important Information
Most SkinMedica® products are intended to meet
the FDA's definition of a cosmetic product, an article applied to
the human body to cleanse, beautify, promote attractiveness, and
alter appearances. These SkinMedica® products are not
intended to be drug products that diagnose, treat, cure, or prevent
any disease or condition. These products have not been approved by
the FDA and the statements have not been evaluated by the
FDA.
For more information, please talk to your provider or visit
SkinMedica.com and DiamondGlow.com. To report an adverse reaction,
please call Allergan at 1-800-433-8871.
References:
- Data on file at SkinMedica ®
View original content to download
multimedia:https://www.prnewswire.com/news-releases/skinmedica-revolutionizes-skin-hydration-with-the-introduction-of-ha5-hydra-collagen-replenish--restore-hydrator-302230995.html
SOURCE AbbVie